Cargando…

Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease

BACKGROUND: In autosomal dominant polycystic kidney disease (ADPKD), total kidney volume (TKV) is regarded as an important biomarker of disease progression and different methods are available to assess kidney volume. The purpose of this study was to identify the most efficient kidney volume computat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Kanishka, Caroli, Anna, Quach, Le Van, Petzold, Katja, Bozzetto, Michela, Serra, Andreas L., Remuzzi, Giuseppe, Remuzzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448775/
https://www.ncbi.nlm.nih.gov/pubmed/28558028
http://dx.doi.org/10.1371/journal.pone.0178488
_version_ 1783239626515808256
author Sharma, Kanishka
Caroli, Anna
Quach, Le Van
Petzold, Katja
Bozzetto, Michela
Serra, Andreas L.
Remuzzi, Giuseppe
Remuzzi, Andrea
author_facet Sharma, Kanishka
Caroli, Anna
Quach, Le Van
Petzold, Katja
Bozzetto, Michela
Serra, Andreas L.
Remuzzi, Giuseppe
Remuzzi, Andrea
author_sort Sharma, Kanishka
collection PubMed
description BACKGROUND: In autosomal dominant polycystic kidney disease (ADPKD), total kidney volume (TKV) is regarded as an important biomarker of disease progression and different methods are available to assess kidney volume. The purpose of this study was to identify the most efficient kidney volume computation method to be used in clinical studies evaluating the effectiveness of treatments on ADPKD progression. METHODS AND FINDINGS: We measured single kidney volume (SKV) on two series of MR and CT images from clinical studies on ADPKD (experimental dataset) by two independent operators (expert and beginner), twice, using all of the available methods: polyline manual tracing (reference method), free-hand manual tracing, semi-automatic tracing, Stereology, Mid-slice and Ellipsoid method. Additionally, the expert operator also measured the kidney length. We compared different methods for reproducibility, accuracy, precision, and time required. In addition, we performed a validation study to evaluate the sensitivity of these methods to detect the between-treatment group difference in TKV change over one year, using MR images from a previous clinical study. Reproducibility was higher on CT than MR for all methods, being highest for manual and semiautomatic contouring methods (planimetry). On MR, planimetry showed highest accuracy and precision, while on CT accuracy and precision of both planimetry and Stereology methods were comparable. Mid-slice and Ellipsoid method, as well as kidney length were fast but provided only a rough estimate of kidney volume. The results of the validation study indicated that planimetry and Stereology allow using an importantly lower number of patients to detect changes in kidney volume induced by drug treatment as compared to other methods. CONCLUSIONS: Planimetry should be preferred over fast and simplified methods for accurately monitoring ADPKD progression and assessing drug treatment effects. Expert operators, especially on MR images, are required for performing reliable estimation of kidney volume. The use of efficient TKV quantification methods considerably reduces the number of patients to enrol in clinical investigations, making them more feasible and significant.
format Online
Article
Text
id pubmed-5448775
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54487752017-06-15 Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease Sharma, Kanishka Caroli, Anna Quach, Le Van Petzold, Katja Bozzetto, Michela Serra, Andreas L. Remuzzi, Giuseppe Remuzzi, Andrea PLoS One Research Article BACKGROUND: In autosomal dominant polycystic kidney disease (ADPKD), total kidney volume (TKV) is regarded as an important biomarker of disease progression and different methods are available to assess kidney volume. The purpose of this study was to identify the most efficient kidney volume computation method to be used in clinical studies evaluating the effectiveness of treatments on ADPKD progression. METHODS AND FINDINGS: We measured single kidney volume (SKV) on two series of MR and CT images from clinical studies on ADPKD (experimental dataset) by two independent operators (expert and beginner), twice, using all of the available methods: polyline manual tracing (reference method), free-hand manual tracing, semi-automatic tracing, Stereology, Mid-slice and Ellipsoid method. Additionally, the expert operator also measured the kidney length. We compared different methods for reproducibility, accuracy, precision, and time required. In addition, we performed a validation study to evaluate the sensitivity of these methods to detect the between-treatment group difference in TKV change over one year, using MR images from a previous clinical study. Reproducibility was higher on CT than MR for all methods, being highest for manual and semiautomatic contouring methods (planimetry). On MR, planimetry showed highest accuracy and precision, while on CT accuracy and precision of both planimetry and Stereology methods were comparable. Mid-slice and Ellipsoid method, as well as kidney length were fast but provided only a rough estimate of kidney volume. The results of the validation study indicated that planimetry and Stereology allow using an importantly lower number of patients to detect changes in kidney volume induced by drug treatment as compared to other methods. CONCLUSIONS: Planimetry should be preferred over fast and simplified methods for accurately monitoring ADPKD progression and assessing drug treatment effects. Expert operators, especially on MR images, are required for performing reliable estimation of kidney volume. The use of efficient TKV quantification methods considerably reduces the number of patients to enrol in clinical investigations, making them more feasible and significant. Public Library of Science 2017-05-30 /pmc/articles/PMC5448775/ /pubmed/28558028 http://dx.doi.org/10.1371/journal.pone.0178488 Text en © 2017 Sharma et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sharma, Kanishka
Caroli, Anna
Quach, Le Van
Petzold, Katja
Bozzetto, Michela
Serra, Andreas L.
Remuzzi, Giuseppe
Remuzzi, Andrea
Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
title Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
title_full Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
title_fullStr Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
title_full_unstemmed Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
title_short Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
title_sort kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448775/
https://www.ncbi.nlm.nih.gov/pubmed/28558028
http://dx.doi.org/10.1371/journal.pone.0178488
work_keys_str_mv AT sharmakanishka kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT carolianna kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT quachlevan kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT petzoldkatja kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT bozzettomichela kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT serraandreasl kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT remuzzigiuseppe kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease
AT remuzziandrea kidneyvolumemeasurementmethodsforclinicalstudiesonautosomaldominantpolycystickidneydisease